Rectovaginal Fistula Repair
Sponsor
Uppsala University (Other)
Overall Status
Completed
CT.gov ID
NCT05006586
Collaborator
(none)
55
1
7
7.9
Study Details
Study Description
Brief Summary
This study is a prospective evaluation of quality-of-life after rectovaginal fistula repair at our institution
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
All patient having undergone rectovaginal fistula repair at Uppsala University Hospital 2003-2018. An invitation to join the study was sent to all patients. Those who answered were then sent Rand 36/SF36 questionnaire as a follow-up together with some general questions concerning whether the rectovaginal fistula was healed or not.
Study Design
Study Type:
Observational
Actual Enrollment
:
55 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Rectovaginal Fistula Repair Predictors of Outcome and Results After Surgical Management
Actual Study Start Date
:
Sep 15, 2020
Actual Primary Completion Date
:
Mar 15, 2021
Actual Study Completion Date
:
Apr 15, 2021
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
RVF All patients having undergone repair for rectovaginal fistula |
Outcome Measures
Primary Outcome Measures
- Surgical repair [Assessed on average 3 months postoperatively]
Rate of fistula closure
Secondary Outcome Measures
- Health-related Quality-of-life [Through study completion, on average 10 years]
SF36 questionnaire
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Undergone RVF repair at Uppsala University Hospital 2003-2018
Exclusion Criteria:
- Fistula due to gender reconstructive surgery
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Akademiska Sjukhuset (Uppsala University hospital) | Uppsala | Sweden | 75185 |
Sponsors and Collaborators
- Uppsala University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Uppsala University
ClinicalTrials.gov Identifier:
NCT05006586
Other Study ID Numbers:
- RVF - quality of life
First Posted:
Aug 16, 2021
Last Update Posted:
Aug 16, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Uppsala University
Additional relevant MeSH terms: